EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

The multifaced role of the macrophage migration inhibitory factor family in organ fibrosis

Lea Herkens iD, Patrick Droste iD, Peter Boor iD

American Journal of Physiology-Cell Physiology · 2025

DOI: 10.1152/ajpcell.00198.2025 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Lea Herkens und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pathology, Uniklinik RWTH, Aachen, Germany. Hauptthemen laut MEDLINE: Macrophage Migration-Inhibitory Factors, Intramolecular Oxidoreductases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: RWTH Aachen | Medizinische Fakultät, RWTH Aachen University (Faculty of Medicine, RWTH Aachen University), Deutsche Forschungsgemeinschaft (DFG), EC | European Research Council (ERC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The macrophage migration inhibitory factor (MIF) family consists of the structurally homologous proteins MIF, D-dopachrome tautomerase (D-DT), and D-DT like (D-DTL). Although MIF is the most well-described member, much less is known about D-DT, and very little about D-DTL. Here, we provide an overview of the structure, similarities, and biological functions of these proteins. MIF and D-DT can have both protective and aggravating effects on various diseases depending on the disease type, involved organ, cell type, and disease stage. Given that the pathological consequence of many chronic diseases is fibrosis, we here discuss the role of these proteins in organ fibrosis, particularly of the kidney, liver, heart, lung, and skin. We discuss the various roles of these proteins, suggesting that MIF might have pro- and antifibrotic roles in different organs. To date, D-DT has been shown to have only antifibrotic roles. We tackle potential translational considerations and propose future research avenues to better understand the involvement of MIF family in organ fibrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Macrophage Migration-Inhibitory FactorsIntramolecular OxidoreductasesHumansFibrosisAnimalsKidneyLiverLung

Stichwörter der Autor:innen

CD74D-DTD-DTLclinical trials

Substanzen

Macrophage Migration-Inhibitory FactorsIntramolecular Oxidoreductasesdopachrome isomeraseMIF protein, human

Autor:innen und Institutionen

  • Institute of Pathology, Uniklinik RWTH, Aachen, Germany.
  • Division of Nephrology and Clinical Immunology, Uniklinik RWTH, Aachen, Germany.
  • Electron Microscopy Facility, Uniklinik RWTH, Aachen, Germany.

ORCID-Profile: Lea Herkens, Patrick Droste, Peter Boor

Förderung

  • RWTH Aachen | Medizinische Fakultät, RWTH Aachen University (Faculty of Medicine, RWTH Aachen University)
  • Deutsche Forschungsgemeinschaft (DFG)
  • EC | European Research Council (ERC)
  • European Research Council
  • Bundesministerium für Bildung und Forschung (BMBF)

Zitieren

APA

Herkens, L., Droste, P., & Boor, P. (2025). The multifaced role of the macrophage migration inhibitory factor family in organ fibrosis. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00198.2025

Vancouver

Herkens L, Droste P, Boor P. The multifaced role of the macrophage migration inhibitory factor family in organ fibrosis. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00198.2025

BibTeX
@article{Herkens2025,
  author = {Herkens, Lea and Droste, Patrick and Boor, Peter},
  title = {The multifaced role of the macrophage migration inhibitory factor family in organ fibrosis},
  journal = {American Journal of Physiology-Cell Physiology},
  year = {2025},
  doi = {10.1152/ajpcell.00198.2025}
}
Kostenlos starten →